10x Genomics, Inc. Increase (Decrease) in Accrued Liabilities
10x Genomics, Inc. (TXG) reported Increase (Decrease) in Accrued Liabilities of -$613.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-05-08
- 10x Genomics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$613.00K.
- 10x Genomics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was $0.00.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month |
|---|---|
| 2026-03-31 | -$613.00K 10-Q · filed 2026-05-08 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 |